Regencell Bioscience Holdings Limited
RGC
$32.00
-$2.34-6.81%
NASDAQ
| 06/30/2024 | 03/31/2024 | 06/30/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.96M | 7.96M | 11.56M | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 152.80K | 152.80K | 56.50K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 14.19M | 14.19M |
| Total Current Assets | 8.11M | 8.11M | 11.62M | 14.19M | 14.19M |
|
|
|||||
| Total Current Assets | 8.11M | 8.11M | 11.62M | 14.19M | 14.19M |
| Net Property, Plant & Equipment | 226.50K | 226.50K | 891.90K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 97.70K | 97.70K | 108.50K | 1.36M | 1.36M |
| Total Assets | 8.44M | 8.44M | 12.62M | 15.55M | 15.55M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 125.30K | 125.30K | 158.10K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 59.80K | 59.80K | 438.30K | -- | -- |
| Total Finance Division Other Current Liabilities | 8.40K | 8.40K | 10.60K | -- | -- |
| Total Other Current Liabilities | 8.40K | 8.40K | 10.60K | -- | -- |
| Total Current Liabilities | 193.60K | 193.60K | 606.90K | -- | -- |
|
|
|||||
| Total Current Liabilities | 193.60K | 193.60K | 606.90K | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.90K | 25.90K | 25.40K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 873.80K | 873.80K |
| Total Liabilities | 219.50K | 219.50K | 632.30K | 873.80K | 873.80K |
|
|
|||||
| Common Stock & APIC | 29.88M | 29.88M | 29.43M | 14.67M | 14.67M |
| Retained Earnings | -21.62M | -21.62M | -17.32M | -- | -- |
| Treasury Stock & Other | -45.80K | -45.80K | -86.70K | -- | -- |
| Total Common Equity | 8.22M | 8.22M | 12.03M | 14.67M | 14.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.22M | 8.22M | 12.03M | 14.67M | 14.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -40.90K | -- | -- |
| Total Equity | 8.22M | 8.22M | 11.99M | 14.67M | 14.67M |
|
|
|||||